Synonyms: 4-aminosalicylic acid | Granupas® | p-aminosalicylic acid | Paser® | Rezipas®
para-aminosalicylic acid is an approved drug (FDA, EMA (2014))
Compound class:
Synthetic organic
Comment: Para-aminosalicylic acid is a structural analogue of 4-aminobenzoic acid (pABA) with activity against mycobacteria. It was one of the first drugs to be introduced as a treatment for tuberculosis (TB) [2-3].
|
|
References |
1. Chakraborty S, Gruber T, Barry 3rd CE, Boshoff HI, Rhee KY. (2013)
Para-aminosalicylic acid acts as an alternative substrate of folate metabolism in Mycobacterium tuberculosis. Science, 339 (6115): 88-91. [PMID:23118010] |
2. Donald PR, Diacon AH. (2015)
Para-aminosalicylic acid: the return of an old friend. Lancet Infect Dis, 15 (9): 1091-1099. [PMID:26277036] |
3. Lehmann J. (1946)
Para-aminosalicylic acid in the treatment of tuberculosis. Lancet, 1 (6384): 15. [PMID:21008766] |
4. Zheng J, Rubin EJ, Bifani P, Mathys V, Lim V, Au M, Jang J, Nam J, Dick T, Walker JR et al.. (2013)
para-Aminosalicylic acid is a prodrug targeting dihydrofolate reductase in Mycobacterium tuberculosis. J Biol Chem, 288 (32): 23447-56. [PMID:23779105] |